Stay updated on Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.

Latest updates to the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page's revision label updated from v3.6.0 to v3.6.3, signaling a new software build behind the page. This change does not alter the study details or user-visible content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRecruitment status updated to reflect no participant enrollment. The page's navigation and content structure were refreshed with new sections (How to Read a Study Record, Common Questions, How to Join a Study) and a revised Intervention/Treatment heading, while the older Intervention / Treatment heading was removed and the revision label updated to v3.6.0.SummaryDifference0.6%

- Check30 days agoChange DetectedThe page now displays a new revision label, v3.5.5, replacing the previous v3.5.4, indicating an update to the page's version and related metadata rather than the study content.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry was added: v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the document or system rather than changes visible to users.SummaryDifference0.1%

- Check73 days agoChange DetectedThe site’s revision/version indicator changed from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check80 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.